MA53666A - Purification de stérol - Google Patents
Purification de stérolInfo
- Publication number
- MA53666A MA53666A MA053666A MA53666A MA53666A MA 53666 A MA53666 A MA 53666A MA 053666 A MA053666 A MA 053666A MA 53666 A MA53666 A MA 53666A MA 53666 A MA53666 A MA 53666A
- Authority
- MA
- Morocco
- Prior art keywords
- sterol
- purification
- sterol purification
- Prior art date
Links
- 229930182558 Sterol Natural products 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
- 150000003432 sterols Chemical class 0.000 title 1
- 235000003702 sterols Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Otolaryngology (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862733522P | 2018-09-19 | 2018-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53666A true MA53666A (fr) | 2021-07-28 |
Family
ID=69888799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053666A MA53666A (fr) | 2018-09-19 | 2019-09-19 | Purification de stérol |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210347810A1 (fr) |
| EP (1) | EP3852765A4 (fr) |
| JP (1) | JP2022501371A (fr) |
| CA (1) | CA3112878A1 (fr) |
| MA (1) | MA53666A (fr) |
| WO (1) | WO2020061317A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115684404B (zh) * | 2022-10-27 | 2024-12-13 | 广东省科学院动物研究所 | 一种冬虫夏草的指纹图谱构建方法及应用 |
| KR20260009808A (ko) * | 2023-04-14 | 2026-01-20 | 베이징 지타이 라이프 사이언시스 엘티디 | 지질 나노입자 조성물 및 이의 용도 |
| MA62195B1 (fr) * | 2023-09-01 | 2025-07-31 | École Supérieure Des Industries Du Textile Et De L'habillement (Esith) | Composition ayant une activité antitumoral obtenues à partir de dérivés de molécules d’extrait de la plante d’alfa |
| EP4700037A1 (fr) * | 2024-08-20 | 2026-02-25 | Otto-von-Guericke-Universität Magdeburg Körperschaft des Öffentlichen Rechts | Synthèse de dérivés du cholestérol marqués par des isotopes comme agents de diagnostic |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1002346A (en) * | 1963-10-10 | 1965-08-25 | Searle & Co | Aminoalkyl esters of 3ª‰-hydroxypregn-5-en-20-one |
| US6645953B2 (en) * | 1995-06-23 | 2003-11-11 | Novo Nordisk A/S | Meiosis regulating compounds |
| AU2946600A (en) * | 1999-03-04 | 2000-09-21 | Eugene Science Inc. | Water-soluble sterol derivative for inhibiting cholesterol absorption and process for preparing the same |
| EP2430168B1 (fr) * | 2009-05-16 | 2016-12-21 | Kunyuan Cui | Compositions comprenant des amphiphiles et des colipides cationiques pour administrer des molécules thérapeutiques |
| ME03091B (fr) * | 2009-12-01 | 2019-01-20 | Translate Bio Inc | Administration d'arnm pour l'augmentation des protéines et des enzymes dans des maladies génétiques humaines |
| CN102978272B (zh) * | 2011-09-06 | 2014-10-15 | 江南大学 | 一种植物甾烷醇衍生物的制备方法 |
| RU2014125435A (ru) * | 2011-11-24 | 2015-12-27 | Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) | Способ получения производных стерина |
| FR3024361B1 (fr) * | 2014-07-30 | 2017-11-24 | Affichem | Utilisation de derives de sterols pour traitement de la perte auditive neurosensorielle et composition correspondante |
| CN104402960B (zh) * | 2014-12-16 | 2016-01-13 | 吉林农业大学 | 糠酸环戊烷并多氢菲酯a及其提取方法和药物用途 |
| KR101796822B1 (ko) * | 2015-02-12 | 2017-11-10 | 계명대학교 산학협력단 | 나노 운반체 및 이를 함유하는 피부 외용제 조성물 |
| US20170325457A1 (en) * | 2016-04-28 | 2017-11-16 | Preceres Inc. | Formulations for the delivery of active agents to insects, plants, and plant pathogens |
| CN106987024B (zh) * | 2017-04-13 | 2019-02-05 | 东南大学 | 一种红外兼容微波纳米复合吸波材料及其制备方法 |
-
2019
- 2019-09-19 MA MA053666A patent/MA53666A/fr unknown
- 2019-09-19 JP JP2021515509A patent/JP2022501371A/ja not_active Ceased
- 2019-09-19 CA CA3112878A patent/CA3112878A1/fr active Pending
- 2019-09-19 EP EP19862992.5A patent/EP3852765A4/fr active Pending
- 2019-09-19 WO PCT/US2019/051940 patent/WO2020061317A1/fr not_active Ceased
- 2019-09-19 US US17/278,095 patent/US20210347810A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022501371A (ja) | 2022-01-06 |
| EP3852765A1 (fr) | 2021-07-28 |
| US20210347810A1 (en) | 2021-11-11 |
| WO2020061317A1 (fr) | 2020-03-26 |
| EP3852765A4 (fr) | 2022-06-22 |
| CA3112878A1 (fr) | 2020-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3555124C0 (fr) | Tcr nyeso | |
| EP3928275A4 (fr) | Système de microprêt | |
| EP3781060A4 (fr) | Cryosonde | |
| EP4007967A4 (fr) | Unité de multiplication-accumulation | |
| EP3736029A4 (fr) | Structure de raccordement | |
| PT4039675T (pt) | Compostos de fenil-2-hidroxi-acetilamino-2-metil-fenilo | |
| EP3784463A4 (fr) | Fluorosulfones | |
| EP3805381A4 (fr) | Phytase mutée | |
| EP3705735A4 (fr) | Structure assemblée de chevauchement | |
| DK3829402T3 (da) | Tæppe | |
| EP3885347A4 (fr) | Dérivé de dihydropyrrolopyrazole | |
| EP4069093A4 (fr) | Système de bio-impression | |
| EP3745904C0 (fr) | Poignée de bâton | |
| EP3852765A4 (fr) | Purification de stérol | |
| EP3721129A4 (fr) | Cryosphère | |
| PT3796975T (pt) | Derivados de sulfonilaminobenzamida | |
| EP3979930C0 (fr) | Système de micro-introducteur | |
| EP3844177A4 (fr) | Polythérapies | |
| EP3770162A4 (fr) | Dérivé de dihydrochromène | |
| DK3587968T3 (da) | Fluidsystem | |
| PL3741550T3 (pl) | Układ | |
| EP3899252C0 (fr) | Système de désaccordeur | |
| EP3708725C0 (fr) | Dispositif formant siphon | |
| EP3741757A4 (fr) | Dérivé de dihydro-indolizinone | |
| EP3773733A4 (fr) | Métallo-liothyronine |